This is a 2-day virtual clinical course on childhood and adult neuromuscular disorders covering a range of disorders including Duchenne’s muscular dystrophy (DMD) and other muscular dystrophies, spinal muscular atrophy, (SMA), neuropathies, myopathies, channelopathies and mitochondrial disorders. This year there will be a particular emphasis on transitional diseases i.e. diseases which start in childhood but need to be managed throughout life including DMD and SMA. Recent advances in therapies for these conditions will be covered. This 2-day course is designed for paediatric and adult specialists with an interest in neuromuscular diseases.
|Costs for 2021|
|Trainee/ Allied health professionals rate (UK)||£25|
Course co-ordinator Jacky Bauer firstname.lastname@example.org
0044 203 448 8111
RCP and RCPCH CPD approval will be applied for
This meeting is sponsored by Sanofi Genzyme. The company has had no input into the content or agenda of this meeting. As part of the sponsorship, slides supplied by Sanofi will be shown during the breaks.
Published on 30 March 2021.